Covered recipient · General Payments record
RICK PLAYER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,450.58
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $343.60 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $149.01 | 8 |
| Amgen Inc. | $70.17 | 3 |
| La Jolla Pharmaceutical Company | $34.85 | 2 |
| GlaxoSmithKline, LLC. | $33.16 | 2 |
| Insmed, Inc. | $22.89 | 1 |
| Abbott Laboratories | $20.22 | 1 |
| Novo Nordisk AS | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.22 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125307609 | CMS |
| Amgen Inc. | $21.62 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657113 | CMS |
| Amgen Inc. | $27.04 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657115 | CMS |
| Amgen Inc. | $21.51 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116022035 | CMS |
| GlaxoSmithKline, LLC. | $15.24 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116137555 | CMS |
| GlaxoSmithKline, LLC. | $17.92 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116265494 | CMS |
| Insmed, Inc. | $22.89 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089568625 | CMS |
| La Jolla Pharmaceutical Company | $17.34 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154250460 | CMS |
| La Jolla Pharmaceutical Company | $17.51 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154250462 | CMS |
| Novo Nordisk Inc | $13.30 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097723772 | CMS |
| PFIZER INC. | $19.48 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131798645 | CMS |
| PFIZER INC. | $19.26 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131800194 | CMS |
| PFIZER INC. | $20.25 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131801246 | CMS |
| PFIZER INC. | $19.48 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131796600 | CMS |
| PFIZER INC. | $17.78 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131855912 | CMS |
| PFIZER INC. | $17.78 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131968373 | CMS |
| PFIZER INC. | $17.49 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132115467 | CMS |
| PFIZER INC. | $17.49 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131043669 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.